Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK government to consult on value-based pricing in December

This article was originally published in Scrip

Executive Summary

Pharmaceutical companies operating in the UK may soon have a clearer idea of the shape of the new value based pricing (VBP) system for setting the price of drugs. The Department of Health will launch a consultation on proposals for VBP next month, according to the department's Business Plan 2011-2015. The government expects the new system to be up and running in January 2014, ready to replace the current Pharmaceutical Price Regulation Scheme when it comes to an end. The department will actually begin developing the system, together with pharmaceutical companies, next April. Value-based pricing forms part of the UK coalition government's plans to overhaul the National Health System to create a "patient-led NHS" and to improve healthcare outcomes.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel